TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T51408	Adrenergic receptor beta-3	B38NAG	N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(4-octyl-3,5-dioxo-[1,2,4]triazolidin-1-yl)-benzenesulfonamide	Investigative	44461468	C31H40N6O5S	608.8	CCCCCCCCN1C(=O)NN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 10000000 nM	Non binder
T51408	Adrenergic receptor beta-3	B4EM0H	4-(1-Hexyl-5-oxo-1,5-dihydro-[1,2,4]triazol-4-yl)-N-{4-[2-(2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44461485	C29H36N6O4S	564.7	CCCCCCN1C(=O)N(C=N1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 10000000 nM	Non binder
T51408	Adrenergic receptor beta-3	B6HRE9	4-(3-Hexyl-4-methyl-2-oxo-2,3-dihydro-imidazol-1-yl)-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44461717	C31H39N5O4S	577.7	CCCCCCN1C(=CN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O)C	EC50 = 12302687.71 nM	Non binder
T51408	Adrenergic receptor beta-3	B7CU3O	N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(4-octyl-5-oxo-[1,2,4]triazolidin-1-yl)-benzenesulfonamide	Investigative	44461496	C31H42N6O4S	594.8	CCCCCCCCN1CNN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 186208713.7 nM	Non binder
T51408	Adrenergic receptor beta-3	B7RT4H	4-(4-Hexyl-5-oxo-4,5-dihydro-[1,2,4]triazol-1-yl)-N-{4-[2-(2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44461486	C29H36N6O4S	564.7	CCCCCCN1C=NN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 165958690.7 nM	Non binder
T51408	Adrenergic receptor beta-3	B9XC0I	4-(3-Hexyl-2-oxo-imidazolidin-1-yl)-N-{4-[2-(2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	10099459	C30H39N5O4S	565.7	CCCCCCN1CCN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 56234132.52 nM	Non binder
T51408	Adrenergic receptor beta-3	BDY9H6	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(4-methyl-3-octyl-2-oxo-2,3-dihydro-imidazol-1-yl)-benzenesulfonamide	Investigative	44461716	C33H43N5O4S	605.8	CCCCCCCCN1C(=CN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O)C	EC50 = 16595869.07 nM	Non binder
T51408	Adrenergic receptor beta-3	BJEO09	4-(3-Hexyl-2-oxo-2,3-dihydro-imidazol-1-yl)-N-{4-[2-(2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	10347866	C30H37N5O4S	563.7	CCCCCCN1C=CN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 70794578.44 nM	Non binder
T51408	Adrenergic receptor beta-3	BKS25R	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(4,4,5,5,5-pentafluoro-pentyl)-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44461719	C29H32F5N5O4S	641.7	C1CN(C(=O)N1CCCC(C(F)(F)F)(F)F)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 70794578.44 nM	Non binder
T51408	Adrenergic receptor beta-3	BLN0D4	N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(1-octyl-5-oxo-[1,2,4]triazolidin-4-yl)-benzenesulfonamide	Investigative	44461490	C31H42N6O4S	594.8	CCCCCCCCN1C(=O)N(CN1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 66069344.8 nM	Non binder
T51408	Adrenergic receptor beta-3	BOP10T	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(4,4,4-trifluoro-butyl)-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44461489	C28H32F3N5O4S	591.6	C1CN(C(=O)N1CCCC(F)(F)F)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 54954087.39 nM	Non binder
T51408	Adrenergic receptor beta-3	BS51DE	N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(3-octyl-2-oxo-imidazolidin-1-yl)-benzenesulfonamide	Investigative	15523859	C32H43N5O4S	593.8	CCCCCCCCN1CCN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 457088189.6 nM	Non binder
T51408	Adrenergic receptor beta-3	BU63KD	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(3-oxo-3-pyrrolidin-1-yl-propyl)-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44461488	C31H38N6O5S	606.7	C1CCN(C1)C(=O)CCN2CCN(C2=O)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	EC50 = 7762471.17 nM	Non binder
T51408	Adrenergic receptor beta-3	BY3F8O	N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-(3-octyl-2-oxo-2,3-dihydro-imidazol-1-yl)-benzenesulfonamide	Investigative	44461718	C32H41N5O4S	591.8	CCCCCCCCN1C=CN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	EC50 = 295120922.7 nM	Non binder